← Human Trials & Peer-Reviewed Studies

Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men.

Plain-language guide to PMID 11502785 (2001): double-blind randomized controlled trial of Human Growth Hormone and Testosterone in 110 women.

Key Facts

PMID
11502785
Journal
The Journal of clinical endocrinology and metabolism
Year
2001
Study type
Randomized Controlled Trial
Authors
Münzer T et al. (12 authors)
DOI
10.1210/jcem.86.8.7773

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Human Growth Hormone and Testosterone, published as a randomized controlled trial.

Who Took Part

According to the abstract, 110 women were involved.

By PubMed's age tags, the people studied were older adults, both men and women.

How the Study Was Run

In design terms this was a randomized, double-blind, placebo-controlled and crossover study.

The women were allocated by chance, so the Human Growth Hormone group and the comparison group should start out alike.

As a double-blind Human Growth Hormone study, the assignments were hidden from both participants and investigators until the end.

The comparison arm used a placebo, so changes seen with Human Growth Hormone could be set against what happens without it.

In the crossover set-up each of the women took both Human Growth Hormone and the comparison in turn, acting as their own control.

What Was Measured

The subject headings attached to it are Abdomen, Adipose Tissue, Body Mass Index, Estradiol, Estrogen Replacement Therapy, Human Growth Hormone and Insulin-Like Growth Factor I.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Human Growth Hormone and Testosterone in 110 women.

The publication is from 2001 (The Journal of clinical endocrinology and metabolism), a journal based in United States.

More context: the related Exogenous HGH, sermorelin & older GHRPs (why they're passed over) library page, all human trials.

Related Library Page

Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.